Comparison of different bone-biopsy techniques for qualitative and quantitative diagnosis of metabolic bone diseases
- PMID: 6361037
Comparison of different bone-biopsy techniques for qualitative and quantitative diagnosis of metabolic bone diseases
Abstract
In this study we evaluated different biopsy techniques for the quantitative study of bone histology. Bone biopsies were done using an electric drill and a Jamshidi needle after tetracycline double-labeling in patients with renal bone disease, osteoporosis, or Paget's disease. Bone slides were stained with Masson-Goldner stain and evaluated for quantitative static and dynamic parameters of bone structure, formation, and resorption. Statistical evaluation of the differences and correlations between histomorphometric parameters obtained from slides of bone samples thirty-five millimeters long and five or three millimeters in diameter revealed that three-millimeter samples were sufficient for qualitative diagnosis but were not optimum for the quantitative evaluation of cellular parameters of resorption and dynamic parameters of formation. A useful compromise might be the use of a four-millimeter specimen obtained with the less invasive technique that hitherto has been employed only for smaller samples.
Clinical relevance: Several bone-biopsy techniques are available that provide bone samples of different sizes. Knowledge of the smallest sample size that is sufficient for qualitative and quantitative diagnosis of metabolic bone diseases will help the physician to select the least-invasive techniques without losing relevant information.
Similar articles
-
[Bone histology in postmenopausal osteoporosis--variations in cellular activity].Acta Med Croatica. 2004;58(1):5-11. Acta Med Croatica. 2004. PMID: 15125387 Croatian.
-
Uses and limitations of bone biopsy in management of metabolic bone disease.Baillieres Clin Endocrinol Metab. 1988 Feb;2(1):31-57. doi: 10.1016/s0950-351x(88)80007-7. Baillieres Clin Endocrinol Metab. 1988. PMID: 3044332 Review.
-
The tissue pathologic features of metabolic bone disease.Orthop Clin North Am. 1984 Oct;15(4):613-29. Orthop Clin North Am. 1984. PMID: 6493734
-
The tissue diagnosis of metabolic bone disease. Role of histomorphometry.Orthop Clin North Am. 1990 Jan;21(1):65-79. Orthop Clin North Am. 1990. PMID: 2296460
-
Bone histomorphometry: a concise review for endocrinologists and clinicians.Arq Bras Endocrinol Metabol. 2010 Mar;54(2):87-98. doi: 10.1590/s0004-27302010000200002. Arq Bras Endocrinol Metabol. 2010. PMID: 20485895 Review.
Cited by
-
Prevalence of low bone formation in untreated patients with osteoporosis.PLoS One. 2022 Jul 19;17(7):e0271555. doi: 10.1371/journal.pone.0271555. eCollection 2022. PLoS One. 2022. PMID: 35853025 Free PMC article.
-
Utility of iliac crest tetracycline-labelled bone biopsy in osteoporosis and metabolic bone disease: An evaluation of 95 cases over a period of 25 years.Bone Rep. 2023 Sep 24;19:101715. doi: 10.1016/j.bonr.2023.101715. eCollection 2023 Dec. Bone Rep. 2023. PMID: 37811524 Free PMC article.
-
Interest of Bone Histomorphometry in Bone Pathophysiology Investigation: Foundation, Present, and Future.Front Endocrinol (Lausanne). 2022 Jul 28;13:907914. doi: 10.3389/fendo.2022.907914. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35966102 Free PMC article. Review.
-
Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C.Cancer Chemother Pharmacol. 1993;32(5):359-64. doi: 10.1007/BF00735919. Cancer Chemother Pharmacol. 1993. PMID: 7687933
-
Percutaneous, Imaging-Guided Biopsy of Bone Metastases.Diagnostics (Basel). 2018 Apr 18;8(2):25. doi: 10.3390/diagnostics8020025. Diagnostics (Basel). 2018. PMID: 29670012 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources